Boris Peaker
Stock Analyst
(n/a)
# 4,243
Out of 4,648 analysts
22
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Boris Peaker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AADI Aadi Bioscience | Downgrades: Hold | n/a | $1.96 | - | 2 | Aug 21, 2024 | |
| GLYC GlycoMimetics | Downgrades: Hold | n/a | $0.41 | - | 1 | Jul 26, 2024 | |
| MGNX MacroGenics | Downgrades: Hold | n/a | $3.70 | - | 3 | May 10, 2024 | |
| LNTH Lantheus Holdings | Initiates: Outperform | $100 | $115.45 | -13.38% | 1 | Dec 4, 2023 | |
| ADCT ADC Therapeutics | Downgrades: Market Perform | n/a | $3.02 | - | 1 | Nov 9, 2023 | |
| PCRX Pacira BioSciences | Upgrades: Outperform | $50 | $16.45 | +203.95% | 1 | Aug 3, 2023 | |
| PCVX Vaxcyte | Initiates: Outperform | n/a | $106.49 | - | 1 | Apr 18, 2023 | |
| XNCR Xencor | Initiates: Outperform | n/a | $21.52 | - | 1 | Dec 6, 2022 | |
| EBS Emergent BioSolutions | Maintains: Market Perform | $30 → $29 | $8.78 | +230.30% | 1 | Sep 12, 2022 | |
| CTMX CytomX Therapeutics | Downgrades: Market Perform | n/a | $1.01 | - | 2 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $95 → $102 | $101.87 | +0.13% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.33 | - | 1 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.55 | - | 1 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.08 | - | 1 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $15.36 | - | 1 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.69 | - | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.84 | - | 1 | Jul 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $588.67 | - | 1 | Jun 12, 2017 |
Aadi Bioscience
Aug 21, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.96
Upside: -
GlycoMimetics
Jul 26, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.41
Upside: -
MacroGenics
May 10, 2024
Downgrades: Hold
Price Target: n/a
Current: $3.70
Upside: -
Lantheus Holdings
Dec 4, 2023
Initiates: Outperform
Price Target: $100
Current: $115.45
Upside: -13.38%
ADC Therapeutics
Nov 9, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $3.02
Upside: -
Pacira BioSciences
Aug 3, 2023
Upgrades: Outperform
Price Target: $50
Current: $16.45
Upside: +203.95%
Vaxcyte
Apr 18, 2023
Initiates: Outperform
Price Target: n/a
Current: $106.49
Upside: -
Xencor
Dec 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $21.52
Upside: -
Emergent BioSolutions
Sep 12, 2022
Maintains: Market Perform
Price Target: $30 → $29
Current: $8.78
Upside: +230.30%
CytomX Therapeutics
Jul 11, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $1.01
Upside: -
Jun 27, 2022
Maintains: Market Perform
Price Target: $95 → $102
Current: $101.87
Upside: +0.13%
Mar 15, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $1.33
Upside: -
Mar 3, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $1.55
Upside: -
Aug 13, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.08
Upside: -
Jul 29, 2021
Initiates: Outperform
Price Target: n/a
Current: $15.36
Upside: -
Oct 22, 2018
Initiates: Outperform
Price Target: n/a
Current: $3.69
Upside: -
Jul 24, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.84
Upside: -
Jun 12, 2017
Initiates: Outperform
Price Target: n/a
Current: $588.67
Upside: -